Annual Total Expenses
$67.10 M
+$34.45 M+105.48%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual total expenses is currently $67.10 million, with the most recent change of +$34.45 million (+105.48%) on 31 December 2023. During the last 3 years, it has risen by +$63.94 million (+2018.15%). ACRV annual total expenses is now at all-time high.ACRV Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$25.14 M
+$3.70 M+17.27%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly total expenses is currently $25.14 million, with the most recent change of +$3.70 million (+17.27%) on 30 September 2024. Over the past year, it has increased by +$9.00 million (+55.79%). ACRV quarterly total expenses is now at all-time high.ACRV Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +105.5% | +55.8% |
| 3 y3 years | +2018.2% | +488.8% |
| 5 y5 years | - | - |
ACRV Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2018.2% | at high | +488.8% |
| 5 y | 5 years | at high | +2018.2% | at high | +841.2% |
| alltime | all time | at high | +2018.2% | at high | +841.2% |
Acrivon Therapeutics Common Stock Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.14 M(+17.3%) |
| June 2024 | - | $21.44 M(+21.3%) |
| Mar 2024 | - | $17.67 M(-16.1%) |
| Dec 2023 | $67.10 M(+105.5%) | $21.05 M(+30.5%) |
| Sept 2023 | - | $16.14 M(+4.0%) |
| June 2023 | - | $15.52 M(+7.8%) |
| Mar 2023 | - | $14.39 M(+44.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $32.66 M(+101.8%) | $9.95 M(+3.9%) |
| Sept 2022 | - | $9.57 M(+61.6%) |
| June 2022 | - | $5.92 M(-17.8%) |
| Mar 2022 | - | $7.21 M(+68.9%) |
| Dec 2021 | $16.18 M(+410.9%) | - |
| Dec 2021 | - | $4.27 M(+59.9%) |
| Sept 2021 | - | $2.67 M |
| Dec 2020 | $3.17 M | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual total expenses?
- What is the all time high annual total expenses for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual total expenses year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly total expenses?
- What is the all time high quarterly total expenses for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly total expenses year-on-year change?
What is Acrivon Therapeutics Common Stock annual total expenses?
The current annual total expenses of ACRV is $67.10 M
What is the all time high annual total expenses for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual total expenses is $67.10 M
What is Acrivon Therapeutics Common Stock annual total expenses year-on-year change?
Over the past year, ACRV annual total expenses has changed by +$34.45 M (+105.48%)
What is Acrivon Therapeutics Common Stock quarterly total expenses?
The current quarterly total expenses of ACRV is $25.14 M
What is the all time high quarterly total expenses for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly total expenses is $25.14 M
What is Acrivon Therapeutics Common Stock quarterly total expenses year-on-year change?
Over the past year, ACRV quarterly total expenses has changed by +$9.00 M (+55.79%)